<DOC>
	<DOCNO>NCT01985412</DOCNO>
	<brief_summary>The purpose study determine whether shotgun sequence technology , use detect donor DNA recipient plasma , use rapid , accurate , non-invasive method detect Acute Cellular Rejection ( ACR ) heart transplantation . Currently , heart transplant recipient undergo invasive heart biopsy diagnose ACR . Thus , ongoing need monitor patient development acute chronic rejection , primary goal non-invasive early detection treatment prevent organ damage .</brief_summary>
	<brief_title>Genome Transplant Dynamics : Non-invasive Sequencing-based Diagnosis Rejection</brief_title>
	<detailed_description>Previous attempt develop non-invasive marker graft rejection focus recipient-specific immune response , thus inherent limitation sensitivity selectivity , especially distinguish rejection infection . The investigator ' goal use novel DNA sequence technology develop rapid , inexpensive , non-invasive method monitoring organ transplant recipient graft rejection . The investigator ' research drive fact acute chronic rejection thoracic organ transplant remain major cause patient morbidity mortality , require intense resource utilization . The investigator ' novel approach first focus donor-specific marker acute rejection . The investigator use high throughput next generation sequence monitor proportion cell-free donor DNA recipient DNA recipient 's blood stream marker rejection . This approach enable fact organ transplant also effectively genome transplant , monitor single nucleotide polymorphism specific donor 's genome ( share recipient 's genome ) one measure relative health transplant organ . The investigator ' preliminary study show cell-free donor DNA level serum heart transplant recipient increase prior diagnosis acute rejection endomyocardial biopsy , remain stable low level absence acute rejection .</detailed_description>
	<criteria>1 . All age heart lung transplant recipients 2 . Recipients redo heart redo lung transplant 1 . Patients waitlisted multiple organ transplantation ( e.g . heartkidney , heartliver , heart lung . ) 2 . Unable unwilling return Stanford biopsy followup procedures 3 . Followed Palo Alto VA Hospital transplant surgery ( VA patient transplant Stanford , subsequent clinical care perform VA hospital )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Rejection</keyword>
	<keyword>Transplant</keyword>
	<keyword>Cardiac</keyword>
	<keyword>Pulmonary</keyword>
	<keyword>Heart</keyword>
	<keyword>Lung</keyword>
	<keyword>Cell-Free DNA</keyword>
	<keyword>cfDNA</keyword>
	<keyword>Cell</keyword>
	<keyword>Free</keyword>
	<keyword>DNA</keyword>
	<keyword>Biopsy</keyword>
	<keyword>Non-Invasive</keyword>
</DOC>